Bottom line
SIMYX vs EFAV: the short answer
SIMYX (SIMT Tax-Managed International Managed Volatility Fund) and EFAV (iShares MSCI EAFE Min Vol Factor ETF) are both mutual funds.
But SIMYX is far broader, holding 582 positions to 272 for EFAV, so beyond the top names it adds exposure EFAV doesn't have.
EFAV is cheaper at 0.2% vs 1.13% — a difference of $93 a year per $10,000 invested.
Over five years, SIMYX returned +8.4% a year vs +1.5% for EFAV (reporting dates differ).
Updated Nov 19, 2026
SIMYX vs EFAV side by side
| SIMYX | EFAV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | SEI | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 1.13% | 0.2% |
| Annual cost per $10k | $113 | $20 |
| 10-yr cost on $10k (prospectus) | $1,375 | $255 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +30.1% | +5.3% |
| 5-yr return (annualized) | +8.4% | +1.5% |
| 10-yr return (annualized) | — | +4.3% |
| Best quarter | +14.4% | +13.1% |
| Worst quarter | −20.3% | −16.4% |
| Net assets (fund) | $227.4M | $5.4B |
| Number of holdings | 582 | 272 |
| Portfolio turnover | 66% | 24% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SIMYX | EFAV | Difference |
|---|---|---|---|
| 2024 | +6.2% | +5.3% | +1.0% |
| 2023 | +13.1% | +12.0% | +1.1% |
| 2022 | −11.4% | −14.8% | +3.4% |
| 2021 | +7.8% | +7.0% | +0.8% |
| 2020 | −1.3% | +0.2% | −1.5% |
| 2019 | +15.8% | +16.8% | −1.0% |
| 2018 | −12.1% | −5.8% | −6.3% |
| 2017 | +21.1% | +21.6% | −0.5% |
Source: Fund prospectus bar charts
Holdings overlap
8 of SIMYX's top 25 holdings also appear in EFAV's top 25.
| Holding | SIMYX | EFAV |
|---|---|---|
| Novartis AG | 1.29% | 1.41% |
| Orange Sa | 1.09% | 1.07% |
| Secom Co., Ltd. | 1.07% | 1.55% |
| Novartis AG | 0.97% | 1.41% |
| Koninklijke Ahold Delhaize N.V. | 0.96% | 1.03% |
| Oversea-chinese Banking Corporation Limited | 0.84% | 1.34% |
| Dbs Group Holdings Ltd | 0.72% | 1.45% |
| Koninklijke Ahold Delhaize N.V. | 0.63% | 1.03% |
Source: SEC Form N-PORT
SIMYX top 10
- Novartis AG — 1.29%
- Engie Sa — 1.16%
- Astellas Pharma Inc. — 1.15%
- Orange Sa — 1.09%
- Secom Co., Ltd. — 1.07%
- Bridgestone Corporation — 0.98%
- Novartis AG — 0.97%
- Koninklijke Ahold Delhaize N.V. — 0.96%
- Oversea-chinese Banking Corporation Limited — 0.84%
- Danske Bank A/s — 0.78%
EFAV top 10
- Secom Co., Ltd. — 1.55%
- Iberdrola, S.A. — 1.53%
- Shell Plc — 1.51%
- Equinor Asa — 1.47%
- Eni S.p.a. — 1.46%
- Dbs Group Holdings Ltd — 1.45%
- Takeda Pharmaceutical Company Limited — 1.41%
- Novartis AG — 1.41%
- Totalenergies Se — 1.38%
- Boc Hong Kong (holdings) Limited — 1.38%
FAQ
What is the difference between SIMYX and EFAV?
Which is cheaper, SIMYX or EFAV?
Should I own both SIMYX and EFAV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.